Matthew Haag
Family Medicine · Hinton, WVNPI 1033107016
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.7% of the total across 279 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 18.8% — the pattern of someone who eats at a lot of different presentations. Among family medicine clinicians in WV with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 279 payments — averaging $16.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$883
- AstraZeneca$512
- AbbVie$435
- Lilly USA, LLC$376
- GSK$313
- Boehringer Ingelheim$285
- plus $2K from 19 others
What the payments were for
- Food & beverage$4,674100%
- Education$150%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 58 | $883 |
| AstraZeneca | 27 | $512 |
| AbbVie(2 entities) | 24 | $435 |
| Lilly USA, LLC | 21 | $376 |
| GSK | 21 | $313 |
| Boehringer Ingelheim | 16 | $285 |
| Abbott | 15 | $282 |
| Merck | 18 | $258 |
| Bayer | 15 | $245 |
| Amgen | 14 | $207 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 13 | $202 |
| Mylan Specialty L.p. | 9 | $191 |
| Novartis | 6 | $117 |
| Exact Sciences | 3 | $64 |
| Biogen | 4 | $54 |
| Eisai Inc. | 3 | $49 |
| Vifor Pharma, Inc. | 1 | $41 |
| Pfizer | 2 | $34 |
| Corium, LLC | 2 | $30 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $23 |
| Dexcom, Inc. | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
| E.r. Squibb & Sons, L.L.C. | 1 | $15 |
| Biodelivery Sciences International, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$120
How this compares
$4,689 in reported general payments places this provider in the 90th percentile of 843 family medicine providers in West Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 82 | $112,236 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 73 | $56,141 |
| JardianceEmpagliflozin | 40 | $52,407 |
| EliquisApixaban | 39 | $42,185 |
| TrulicityDulaglutide | 21 | $29,816 |
| FarxigaDapagliflozin Propanediol | 27 | $28,979 |
| KerendiaFinerenone | 18 | $25,074 |
| LinzessLinaclotide | 25 | $23,825 |
| Tresiba Flextouch U-100Insulin Degludec | 20 | $23,111 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 20 | $19,794 |
| NuedextaDextromethorphan Hbr/Quinidine | 11 | $16,977 |
| MounjaroTirzepatide | 12 | $16,133 |
| Tresiba Flextouch U-200Insulin Degludec | 15 | $13,560 |
| Breo ElliptaFluticasone/Vilanterol | 20 | $9,244 |
| VascepaIcosapent Ethyl | 19 | $8,812 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $883 | $112,23682 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $313 | $65,38593 claims |
| Boehringer IngelheimJardiance | $285 | $52,40740 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $512 | $48,77347 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $376 | $45,94933 claims |
| PfizerEliquis | $34 | $42,18539 claims |
| AbbVieLinzess, Synthroid | $435 | $25,78355 claims |
| BayerKerendia | $245 | $25,07418 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 843 family medicine providers in West Virginia.
Other family medicine in Hinton
- Julie DetempleSouth Charleston$129K
- John CornellHuntington$68K
- Isha WoofterClarksburg$27K
- Dominick WoofterClarksburg$27K
- Ryan RunyonPrinceton$21K
- David HessBridgeport$20K
- Cherry LobatonMartinsburg$19K
- Melissa GamponiaCharleston$18K
- Stephen MascioFollansbee$17K
- Kenneth AdkinsSouth Charleston$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.